{"DataElement":{"publicId":"4614617","version":"1","preferredName":"Neuroendocrine Carcinoma Histopathologic Classification Grade","preferredDefinition":"Text term to describe the degree of cellular differentiation in a neuroendocrine tissue sample.","longName":"NEUR_HISTPATH_GD","context":"CCR","contextVersion":"1","DataElementConcept":{"publicId":"4614597","version":"1","preferredName":"Neuroendocrine Carcinoma Histopathology Classification","preferredDefinition":"A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma._The science or study dealing with the cytologic and histologic structure of abnormal or diseased tissue. SYN pathologic histology. (STED98)_A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"4614594v1.0:4614595v1.0","context":"CCR","contextVersion":"1","ObjectClass":{"publicId":"4614594","version":"1","preferredName":"Neuroendocrine Carcinoma","preferredDefinition":"A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.","longName":"C3773","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"08ED0A2A-980C-C182-E050-BB89AD436A0C","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"ONEDATA","dateModified":"2014-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4614595","version":"1","preferredName":"Histopathology Classification","preferredDefinition":"The science or study dealing with the cytologic and histologic structure of abnormal or diseased tissue. SYN pathologic histology. (STED98):A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","longName":"C0677043:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histopathology","conceptCode":"C0677043","definition":"The science or study dealing with the cytologic and histologic structure of abnormal or diseased tissue. SYN pathologic histology. (STED98)","evsSource":"UMLS_CUI","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08ED0A2A-981D-C182-E050-BB89AD436A0C","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"ONEDATA","dateModified":"2014-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08ED0A2A-982E-C182-E050-BB89AD436A0C","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4614615","version":"1","preferredName":"Neuroendocrine Carcinoma Histopathologic Grade","preferredDefinition":"A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma._A position on a scale of intensity or amount or quality.","longName":"NEUR_PATH_GD","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"30","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"High, Grade 3","valueDescription":"Poorly Differentiated","ValueMeaning":{"publicId":"3685459","version":"1","preferredName":"Poorly Differentiated","longName":"3685459","preferredDefinition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Poorly Differentiated","conceptCode":"C14167","definition":"Describes tumor cells that generally have lost most of the appearance of normal cells. They tend to grow and spread.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"D58D9008-3A3B-3F09-E040-BB89AD4368A5","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2013-02-12","modifiedBy":"GDEEN","dateModified":"2023-07-31","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"08ED0A2A-9870-C182-E050-BB89AD436A0C","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"ONEDATA","dateModified":"2014-11-28","deletedIndicator":"No"},{"value":"Low, Grade 1","valueDescription":"Neuroendocrine Tumor Grade 1","ValueMeaning":{"publicId":"4616031","version":"1","preferredName":"Neuroendocrine Tumor Grade 1","longName":"4616031","preferredDefinition":"Well differentiated tumor with mitotic count <2/10 HPF and Ki-67 Index < or =2","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0927FE3B-D4DF-3FFB-E050-BB89AD4363D7","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0927FE3B-D4F8-3FFB-E050-BB89AD4363D7","beginDate":"2014-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"},{"value":"Intermediate, Grade 2","valueDescription":"Neuroendocrine Tumor Grade 2","ValueMeaning":{"publicId":"4616032","version":"1","preferredName":"Neuroendocrine Tumor Grade 2","longName":"4616032","preferredDefinition":"Well differentiated tumor with mitotic count >2-20/10 HPF and Ki-67 Index 3-20","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"0927FE3B-D502-3FFB-E050-BB89AD4363D7","latestVersionIndicator":"Yes","beginDate":"2014-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"0927FE3B-D51B-3FFB-E050-BB89AD4363D7","beginDate":"2014-12-01","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-12-01","modifiedBy":"ONEDATA","dateModified":"2014-12-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4614614","version":"1","preferredName":"Neuroendocrine Carcinoma Grade","preferredDefinition":"A malignant neuroendocrine neoplasm composed of cells containing secretory granules that stain positive for NSE and chromogranin.  The neoplastic cells are often round and form clusters or trabecular sheets.  Representative examples are small cell carcinoma, large cell neuroendocrine carcinoma, and Merkel cell carcinoma.:A position on a scale of intensity or amount or quality.","longName":"C3773:C48309","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Grade","conceptCode":"C48309","definition":"A position on a scale of intensity or amount or quality.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08ED0A2A-9842-C182-E050-BB89AD436A0C","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"ONEDATA","dateModified":"2014-11-28","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"08ED0A2A-9853-C182-E050-BB89AD436A0C","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"HARTLEYG","dateModified":"2019-11-27","changeDescription":"Created to support NCI CCR clinical trial.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008601","version":"1","longName":"C3D Domain","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811685","version":"1","longName":"CCR","context":"CCR"}]},{"publicId":"2182125","version":"1","longName":"CCR Implementation","context":"CCR","ClassificationSchemeItems":[{"publicId":"2811673","version":"1","longName":"C3D","context":"CCR"}]},{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"10000177","version":"1","longName":"Neuroendocrine","context":"OCG"}]}],"AlternateNames":[{"name":"OCG","type":"USED_BY","context":"OCG"}],"ReferenceDocuments":[{"name":"Neuroendocrine Tumor Histopat","type":"Preferred Question Text","description":"Neuroendocrine Tumor Histopathologic Grade","url":null,"context":"CCR"}],"origin":"CCR:Center for Cancer Research","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"08ED0A2A-98B1-C182-E050-BB89AD436A0C","latestVersionIndicator":"Yes","beginDate":"2014-11-28","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-11-28","modifiedBy":"HARTLEYG","dateModified":"2019-11-27","changeDescription":"Curated to support NCI Center for Cancer Research (CCR) clinical trial. 12.1.2014.dmr","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}